Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

ProMetic Life Sciences Inc T.PLI

Sector: Healthcare | Sub-Sector: Biotechnology

ProMetic Life Sciences Inc is a biopharmaceutical company offering technologies for drug purification, drug development, proteomics, and the elimination of pathogens.
Price: $2.50 | Change: $-0.01 | %Change: -0.40%
Volume: 71,424 | Day High/Low: 2.50/2.48 | 52 Week High/Low: 2.87/0.85
View modes: 
0 stars


Deal late today or early tomorrow imho SKYHIGH  rate and reply
5 stars

level 2 at 9:36 am

# Orders Shares Bid Ask Shares # Orders 8 18700 2.480 2.490 5100 22 5 6800 more
5 stars


Considering that PLI has been delivering year end reports like clockwork for the past three years on the 26 of March. It is somewhat bizarre that they have not even announced the release date more
5 stars

level 2 at 9:25 am

# Orders Shares Bid Ask Shares # Orders 13 27000 2.510 2.510 77200 11 5 9800 more
5 stars

interesting tidbit from cnbc site This is your big chance to buy biotech, traders say Alex Rosenberg | @CNBCAlex 2 Hours Ago 20 SHARES more
1 star


Its getting late but I just noticed that PLI is on the TD website that PLI was one of the days top gainers.And although I would have thought that PLI should have made this list before I have more
3 stars

RE:RE:Canadian bank coverage

PLI has some of the biggest irons in the fire out of any of the biotech company's . Yes there are big eyes watching us Let's hope the  rate and reply
3 stars

RE:Any body following this sky

sky - whos the pin head who marks you a one star all the time.? You have brought good info and passion to your material ! Got to love BB's .  .....  rate and reply
2.5 stars

RE:Canadian bank coverage

You could be right Jack. The big bank coverage is long over due. With all Bio techs, they are hard to evaluate at times...PLI has so many gears in motion and so many orphan drugs , saying a 1 more
0 stars

Canadian bank coverage

For some time there have been comments on when coverage of PLI would be initiated by the Canadian banks.  It seems to me that PBI-4050 is the stumbling block.  How could the banks initiate more
1 star

Any body following this sky

AEMD  rate and reply
1 star

Was this the hold up for the GSK Deal ???

GSK agrees UK deal for meningitis shot after Novartis stand-off Reuters UK‎ - 9 hours ago Britain's GSK earlier this month completed a deal to acquire the ... Nikki Yates, general manager of GSK more
2.5 stars

Read with your Sunday morning coffee

Cells that produce insulin substitutes insulin injection Empire State Tribune‎ - 40 minutes ago The US biotechnology company PharmaCyte Biotech had given their persmission for the team to obtain more
4 stars


PLI is listed as one of the trending stocks on TMX MONEY  rate and reply
1.5 stars

RE:Just wondering if PLI is involed ?

Forgot to add this The medication, known as Ibrance, has been at the head of Pfizer’s pipeline, and represents a big opportunity for the pharmaceutical firm, which has been struggling to more
1.5 stars

Just wondering if PLI is involed ?

.One of five Block Buster Drugs for 2015 Ibrance (palbociclib) Company: Pfizer Treats: Breast cancer Projected Approval Date: April 2015    Ibrance is the next major drug launch in line for more
2.5 stars

RE:Note tp aureus: copying, pasting

uchuck if you go back to the site that had the few lines of info  .Look at the top of your screen and it wil have a address starting with http://        just write down what it is  and we  will more
1 star

Note tp aureus: copying, pasting

I'm a computer dolt, don't know how to do, there was no real heavy-duty text, just a line or two of text.  rate and reply
3 stars

RE:RE:RE:RE:RE:Target by S. Brighton, D. Schilling

Mtnbkr I like the $4 sp that read in a few years ( it was 2013 when this was written) the beacon report  in my view was right on the money .Its going to be Interesting when the banks come out more
4 stars

RE:RE:RE:RE:Target by S. Brighton, D. Schilling

sky- Nice reminder of things in the pipeline with your postInternalizing PPPS to Drive Significant Value   mtnbkr  rate and reply